CH545310A - Verfahren zur Herstellung neuer trisubstituierter Oxazole - Google Patents

Verfahren zur Herstellung neuer trisubstituierter Oxazole

Info

Publication number
CH545310A
CH545310A CH1717171A CH1717171A CH545310A CH 545310 A CH545310 A CH 545310A CH 1717171 A CH1717171 A CH 1717171A CH 1717171 A CH1717171 A CH 1717171A CH 545310 A CH545310 A CH 545310A
Authority
CH
Switzerland
Prior art keywords
preparation
oxazoles
new trisubstituted
new
trisubstituted oxazoles
Prior art date
Application number
CH1717171A
Other languages
English (en)
Inventor
Brown Kevan
Frederick Cavalla John
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of CH545310A publication Critical patent/CH545310A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH1717171A 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole CH545310A (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters

Publications (1)

Publication Number Publication Date
CH545310A true CH545310A (de) 1973-12-15

Family

ID=27516268

Family Applications (9)

Application Number Title Priority Date Filing Date
CH1648872A CH554884A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole.
CH1716971A CH545309A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1716871A CH545308A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters
CH1485573A CH560203A5 (de) 1966-11-18 1967-11-16
CH1717371A CH560205A5 (de) 1966-11-18 1967-11-16
CH1717171A CH545310A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1717271A CH536311A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxagole
CH1717071A CH556351A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole.

Family Applications Before (6)

Application Number Title Priority Date Filing Date
CH1648872A CH554884A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole.
CH1716971A CH545309A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1716871A CH545308A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters
CH1485573A CH560203A5 (de) 1966-11-18 1967-11-16
CH1717371A CH560205A5 (de) 1966-11-18 1967-11-16

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1717271A CH536311A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxagole
CH1717071A CH556351A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole.

Country Status (12)

Country Link
JP (1) JPS4938267B1 (de)
BE (1) BE706625A (de)
CH (9) CH554884A (de)
DE (2) DE1670005C2 (de)
ES (1) ES347319A1 (de)
FI (1) FI50416C (de)
FR (2) FR8018M (de)
IL (1) IL28803A (de)
LU (1) LU54891A1 (de)
NL (1) NL157012B (de)
PL (1) PL72562B1 (de)
SE (2) SE369307B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2618547A1 (de) * 1975-05-02 1976-11-18 Lilly Industries Ltd Oxazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (de) * 1974-07-18 1976-01-30
JPS5182675A (de) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
ES2144403T3 (es) * 1990-11-30 2000-06-16 Otsuka Pharma Co Ltd Derivados de tiazol como inhibidores de oxigeno activo.
WO1996003392A1 (en) * 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (de) * 1965-10-07

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2618547A1 (de) * 1975-05-02 1976-11-18 Lilly Industries Ltd Oxazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
FR8018M (de) 1970-08-03
FI50416C (fi) 1976-03-10
BE706625A (de) 1968-05-16
CH560203A5 (de) 1975-03-27
CH560205A5 (de) 1975-03-27
DE1795822C2 (de) 1982-07-15
CH536311A (de) 1973-04-30
CH556351A (de) 1974-11-29
DE1670005A1 (de) 1970-08-06
LU54891A1 (de) 1968-02-08
IL28803A (en) 1974-05-16
DE1670005C2 (de) 1982-06-09
NL157012B (nl) 1978-06-15
CH545309A (de) 1973-12-15
PL72562B1 (en) 1974-08-30
ES347319A1 (es) 1969-05-16
FI50416B (de) 1975-12-01
CH528531A (de) 1972-09-30
SE369307B (de) 1974-08-19
SE422209B (sv) 1982-02-22
JPS4938267B1 (de) 1974-10-16
NL6715532A (de) 1968-05-20
CH554884A (de) 1974-10-15
CH545308A (de) 1973-12-15
FR1584222A (de) 1969-12-19

Similar Documents

Publication Publication Date Title
CH516512A (de) Verfahren zur Herstellung neuer substituierter 1-Phenoxy-2-aminopropane
CH545309A (de) Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH511856A (de) Verfahren zur Herstellung neuer trisubstituierter 2-Aryl-aminoimidazoline
CH441332A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
AT269137B (de) Verfahren zur Herstellung neuer Oxazolidinderivate
CH482724A (de) Verfahren zur Herstellung neuer Aminooxysilane
AT249047B (de) Verfahren zur Herstellung neuer Benzamidobenzanilid-Derivate
CH443310A (de) Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone
AT278834B (de) Verfahren zur Herstellung neuer Benzotriazinone
CH464204A (de) Verfahren zur Herstellung neuer Isoxazole
AT273146B (de) Verfahren zur Herstellung neuer wachsartiger Triazinylamine
CH489454A (de) Verfahren zur Herstellung neuer a-Halogenxcyclobutanone
CH476689A (de) Verfahren zur Herstellung neuer polymerisierbarer N-Aryl-methylcarbonsäureamide
CH471077A (de) Verfahren zur Herstellung neuer substituierter Aryloxy-2-hydroxy-3-aminopropane
CH459214A (de) Verfahren zur Herstellung neuer Nitrothiazolverbindungen
CH508626A (de) Verfahren zur Herstellung neuer azabicycloaliphatischer Verbindungen
CH487901A (de) Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone
CH467257A (de) Verfahren zur Herstellung neuer Isatin-B-Thiosemicarbazone
AT267775B (de) Verfahren zur Herstellung neuer des-A-5-Oxo-10-hydroxymethylgonadiene
CH474523A (de) Verfahren zur Herstellung neuer 2-Alkyl-3-aryl-3H-4-chinazolone
CH473120A (de) Verfahren zur Herstellung neuer 1-Cycloalkenylpiperidine
AT287672B (de) Verfahren zur Herstellung neuer Peroxyaminoverbindungen
AT244953B (de) Verfahren zur Herstellung neuer 5-Nitro-2-furamidine
CH448337A (de) Verfahren zur Herstellung neuer 1-Amino-2-benzoyl-4-hydroxyanthrachinone
CH509251A (de) Verfahren zur Herstellung neuer substituierter 1-Phenoxy-2-aminoalkane

Legal Events

Date Code Title Description
PL Patent ceased